2030, Drug Research and Therapies - Drug Discovery Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2030

Drug Research

Therapies

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

MAY 20, 2024

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% between 2024 and 2030. between 2024 and 2030. over this period.

Clinical Research

Clinical Research Clinical Trials Research Trials

World Malaria Day 2021

The Pharma Data

APRIL 24, 2021

In 1999, Novartis launched the first fixed-dose Artemisinin-based Combination Therapy (ACT) and in 2009, the first dispersible pediatric ACT developed in partnership with Medicines for Malaria Venture (MMV). Follow us on social media at #MalariaFuture. The EDCTP grant of EUR 21.9 Video of No one should die of malaria. Read the reports.

Clinical Trials

Clinical Trials Treatment Trials Disease

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

World Malaria Day 2021

Stay Connected